InvestorsHub Logo
Followers 19
Posts 4618
Boards Moderated 0
Alias Born 04/12/2017

Re: None

Wednesday, 10/09/2019 7:55:59 AM

Wednesday, October 09, 2019 7:55:59 AM

Post# of 469952

“This is an important development as the patients who have completed the main study, ANAVEX2-73-AD-004, are consistently expressing the wish to gain ongoing access to this investigational therapy,” says A/Professor Stephen Macfarlane, FRANZCP, Head of Clinical Services at the Dementia Centre, HammondCare and Principal Investigator for both studies.



Is this guy Macfarlane getting haircuts at the same shop as Missling?

WOW to those comments, but here comes the "well they would of asked for the sugar pills too out of desperation"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News